{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:25:12Z","timestamp":1790342712835,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.juro.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T04:07:23Z","timestamp":1404878843000},"page":"1822-1830","source":"Crossref","is-referenced-by-count":49,"title":["Expression of the Tumor Suppressive\n            <i>miRNA-23b\/27b<\/i>\n            Cluster is a Good Prognostic Marker in Clear Cell Renal Cell Carcinoma"],"prefix":"10.1097","volume":"192","author":[{"given":"Tomoaki","family":"Ishihara","sequence":"first","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Inoguchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Tatarano","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Itesako","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Enokida","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2014.07.001_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.juro.2014.07.001_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4137\/CMO.S4482","article-title":"Renal cell carcinoma: focus on safety and efficacy of temsirolimus","volume":"4","author":"Hadoux","year":"2010","journal-title":"Clin Med Insights Oncol"},{"issue":"suppl.","key":"10.1016\/j.juro.2014.07.001_bib3","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1093\/jjco\/hyq127","article-title":"Kidney Cancer Working Group report","volume":"40","author":"Naito","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.juro.2014.07.001_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.juro.2014.07.001_bib5","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1158\/1535-7163.MCT-08-0586","article-title":"MicroRNAs and cancer: past, present, and potential future","volume":"7","author":"Nelson","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.juro.2014.07.001_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/cas.12280","article-title":"Tumor-suppressive microRNA-143\/145 cluster targets hexokinase-2 in renal cell carcinoma","volume":"104","author":"Yoshino","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.juro.2014.07.001_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2011.04.110","article-title":"miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation","volume":"186","author":"White","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.07.001_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1476-4598-9-232","article-title":"Cooperative and individualistic functions of the microRNAs in the miR-23a\u223c27a\u223c24-2 cluster and its implication in human diseases","volume":"9","author":"Chhabra","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.juro.2014.07.001_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejca.2011.06.030","article-title":"The functional significance of miR-1 and miR-133a in renal cell carcinoma","volume":"48","author":"Kawakami","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.juro.2014.07.001_bib10","series-title":"Japanese Urological Association, Japanese Society of Pathology and Japan Radiological Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma","year":"1999"},{"key":"10.1016\/j.juro.2014.07.001_bib11","series-title":"TNM Classification of Malignant Tumours","first-page":"255","author":"Sobin","year":"2009"},{"key":"10.1016\/j.juro.2014.07.001_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.18632\/oncotarget.417","article-title":"Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma","volume":"3","author":"Hidaka","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.juro.2014.07.001_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cas.12072","article-title":"Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma","volume":"104","author":"Yamada","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.juro.2014.07.001_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14737140.8.1.63","article-title":"VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment","volume":"8","author":"Rathmell","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.juro.2014.07.001_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1741-7015-8-64","article-title":"The VHL-dependent regulation of microRNAs in renal cancer","volume":"8","author":"Neal","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.juro.2014.07.001_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1464-410x.1999.00202.x","article-title":"Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy","volume":"84","author":"Ljungberg","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2014.07.001_bib17","doi-asserted-by":"crossref","first-page":"e35661","DOI":"10.1371\/journal.pone.0035661","article-title":"Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2014.07.001_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1593\/neo.12734","article-title":"MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients","volume":"14","author":"Gamez-Pozo","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.juro.2014.07.001_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/ijo.2012.1543","article-title":"Tumor suppressive microRNA138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma","volume":"41","author":"Yamasaki","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.juro.2014.07.001_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.juro.2013.02.089","article-title":"MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway","volume":"190","author":"Yamasaki","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.07.001_bib21","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1158\/0008-5472.CAN-12-2181","article-title":"miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer","volume":"72","author":"Majid","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2014.07.001_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.eururo.2011.01.004","article-title":"Accurate molecular classification of kidney cancer subtypes using microRNA signature","volume":"59","author":"Youssef","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2014.07.001_bib23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/0008-5472.CAN-12-2362","article-title":"Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma","volume":"73","author":"An","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2014.07.001_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jmoldx.2012.02.003","article-title":"The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma","volume":"14","author":"Faragalla","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.juro.2014.07.001_bib25","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.juro.2012.11.133","article-title":"A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance","volume":"189","author":"Berkers","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.07.001_bib26","doi-asserted-by":"crossref","first-page":"e52106","DOI":"10.1371\/journal.pone.0052106","article-title":"The microRNA -23b\/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells","volume":"7","author":"Ishteiwy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2014.07.001_bib27","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1158\/0008-5472.CAN-12-2162","article-title":"Prooncogenic factors miR-23b and miR-27b are regulated by Her2\/Neu, EGF, and TNF-alpha in breast cancer","volume":"73","author":"Jin","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2014.07.001_bib28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.26436","article-title":"Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma","volume":"118","author":"Minner","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2014.07.001_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3816\/CGC.2007.n.002","article-title":"The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation","volume":"5","author":"Cohen","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.juro.2014.07.001_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/annonc\/mds463","article-title":"c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma","volume":"24","author":"Gibney","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.juro.2014.07.001_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11523-013-0303-8","article-title":"New agents in\u00a0renal cell carcinoma","volume":"9","author":"Dabney","year":"2014","journal-title":"Target Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534714039354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534714039354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2014.07.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:07:51Z","timestamp":1651205271000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2014.07.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1016\/j.juro.2014.07.001"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2014.07.001","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}